Cancer Clinical Trial -Sirnaomics-SRN-705-005
Cancer
Status:
OpenClinicalTrials.gov:
NCT04676633Safety, Tolerability, PK, Anti-Tumor Activity of STP705 Injected IT in Cholangiocarcinoma, Hepatocellular Carcinoma or Liver Metastases in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy